Gleevec Helps Prevent Return of Type of Gastrointestinal Tumor


Preliminary findings from a large clinical trial expand the potential use for Gleevec, one of a new class of cancer drugs specifically designed to block abnormal proteins that lead to tumor growth.

Comments are closed.